• Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

  • Sep 18 2024
  • Length: 38 mins
  • Podcast

Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

Listen for free

View show details

  • Summary

  • Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available